Directed Evolution of an ( R )‐Selective Transaminase Toward Higher Efficiency of Sitagliptin Analog Biosynthesis
Biotechnology and Bioengineering · 2025-07 · 122 (7) · 1735-1746
DOI: 10.1002/bit.28988 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 08.04.2025. Verfasst von Dong-Xu Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou…. Hauptthemen laut MEDLINE: Sitagliptin Phosphate, Directed Molecular Evolution, Transaminases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: This study was supported by the Program of the National Key Research and Development Project (2020YFA0908400) and the Key Research and Development Program of Z….
Abstract (Originalsprache)
Transaminase (TA)‐catalyzed asymmetric amination is considered as a green chemistry approach to synthesize pharmaceutical analogs, but their ability to accept substrate for catalyzing sterically hindered ketones remains a challenge. Sitagliptin is an antihyperglycemic drug to treat type II diabetes. Herein, we exploited an efficient ( R )‐selective TA to biosynthesize sitagliptin analog ( R )‐3‐amino‐1‐morpholino‐4‐(2,4,5‐trifluorophenyl)butan‐1‐one. Starting from a previously constructed ( R )‐ATA5, two rounds of directed evolution were performed through combining error‐prone PCR, site‐directed saturation and combinatorial mutagenesis. The resultant variant ATA5/F189H/S236T/M121H showed a 10.2‐fold higher activity and a 4‐fold improved half‐life at 45°C. Crucially, the variant was able to either catalyze the amination of 700 mM substrate with a conversion up to 93.1% and product e.e .> 99% in a cosolvent reaction system, or biotransform 200 mM substrate with a conversion of 97.6% and product e.e .> 99% in a cosolvent‐free system. Furthermore, the structural analysis gave insight into how the mutations affected enzymatic activity and thermostability. This study, which consists of constructing a robust ( R )‐selective TA and the new synthesis route with the highest conversion ever reported, provides a reference for industrial manufacturing sitagliptin analog.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China.
- The National and Local Joint Engineering Research Center for Biomanufacturing of Chiral Chemicals, Zhejiang University of Technology, Hangzhou, China.
ORCID-Profile: Dong-Xu Jia, Zhi-Qiang Liu, Yu-Guo Zheng
Förderung
- This study was supported by the Program of the National Key Research and Development Project (2020YFA0908400) and the Key Research and Development Program of Z…
Zitieren
APA
Jia, D. X., Zang, L., Ni, C. D., Wang, J. L., Yu, H., Liu, Z. Q., & Zheng, Y. G. (2025). Directed Evolution of an ( R )‐Selective Transaminase Toward Higher Efficiency of Sitagliptin Analog Biosynthesis. Biotechnology and Bioengineering, 122(7), 1735-1746. https://doi.org/10.1002/bit.28988
Vancouver
Jia DX, Zang L, Ni CD, Wang JL, Yu H, Liu ZQ, et al. Directed Evolution of an ( R )‐Selective Transaminase Toward Higher Efficiency of Sitagliptin Analog Biosynthesis. Biotechnology and Bioengineering. 2025;122(7):1735-1746. doi:10.1002/bit.28988
BibTeX
@article{Jia2025,
author = {Jia, Dong-Xu and Zang, Lei and Ni, Chi-De and Wang, Jia-Le and Yu, Hai and Liu, Zhi-Qiang and Zheng, Yu-Guo},
title = {Directed Evolution of an ( R )‐Selective Transaminase Toward Higher Efficiency of Sitagliptin Analog Biosynthesis},
journal = {Biotechnology and Bioengineering},
year = {2025},
volume = {122},
number = {7},
pages = {1735--1746},
doi = {10.1002/bit.28988}
}
EUVIMED